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Results: The resorption pits made by osteoclasts were well
demonstrated on the cortical bone plates. The area of the re-
sorption pits became larger sequentially on day 3, 5, and 7
in osteoclast-cell culture. In the STZ group, the resorption-pit
area was signiﬁcantly decreased compared with that in control
group. The expression levels of MMP9, Catepsin-K, and RANK
showed no difference in between control and STZ group. On the
other hand, expression levels of DC-STAMP were signiﬁcantly
decreased in STZ group.
Conclusions: In the last meeting, we reported that the osteoclast
fusion was impaired, the cartilage resorption was decreased,
and the endocondral ossiﬁcation was delayed in the STZ-induced
diabetic mice. In this study, we found that the impaired bone
resorption in STZ might be produced by a decreased expression
of DC-STAMP in osteoclasts. Since DC-STAMP has a central role
for the formation of multinuclear osteoclasts, our result indicates
that the up-regulation of DC-STAMP may be useful to prevent
osteopenia in diabetes mellitus.
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Purpose: Recent data showed that subchondral bone plays an
important role in osteoarthritis (OA). Metabolic and morphologic
modiﬁcations in this tissue contribute to the degradation of the
overlaying cartilage. It was suggested that abnormal mechani-
cal pressure applied to the articulation was responsible to these
changes. Here, we evaluated the effects of compression on os-
teoblasts from subchondral bone.
Methods: Osteoblasts were isolated from sclerotic (SC) or non-
sclerotic (NSC) areas of human OA subchondral bone. After 28
days, osteoblasts were surrounded by a newly synthesized ma-
trix and formed a strong membrane. This osteoblasts-containing
membrane was then placed onto a Biopress Flexercell plate and
submitted to compression (1.67 MPa) for 4 hours at the frequency
of 1 Hz. The expression of IL-6, IL-8, COX-2, VEGF, IGF-1, OPG
and RANKL was evaluated by RT-PCR. IL-6, IL-8 and PGE2 were
quantiﬁed by ELISA.
Results: Basal IL-6, VEGF, COX-2, IGF-1 and RANKL mRNA
levels were signiﬁcantly increased in SC osteoblasts as compared
to NSC. By contrast, SC osteoblasts expressed less OPG than
those from NSC areas. Compressions induced the expression of
genes coding for IL-6, IL-8, COX-2, IGF-1, VEGF and RANKL but
decreased the expression of OPG in NSC osteoblasts (p<0.01).
IL-6, IL-8 and PGE2 productions were also stimulated by com-
pressions. Interestingly, compressed NSC osteoblasts expressed
similar levels of these genes than SC osteoblasts, suggesting that
mechanical strains could be responsible for SC phenotype.
Conclusions: These results indicate that in response to com-
pression NSC osteoblasts expressed a phenotype similar to that
of SC osteoblasts. Moreover, SC osteoblasts are less sensitive
to mechanical stimuli than NSC osteoblasts. These results clarify
the role of compression in the pathogenesis of subchondral bone
sclerosis and allow new perspectives of research in this ﬁeld.
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Purpose: Bone tissues are remodeled through cycling of bone re-
sorption and new bone formation that are dependent by the activity
of osteoblasts and osteoclasts. Subchondral bone remodelling in
osteoarthritis (OA) and rheumatoid arthritis (RA) is mainly charac-
terized by the formation of osteophytes/ﬁbrosis and by the pres-
ence of inﬁltrating cells associated to bone resorption. In this study
we analysed on subchondral bone of OA and RA patients both
the expression of CCL20 chemokine and its receptor CCR6 on
osteoblasts, osteoclasts, osteocytes and inﬁltrating mononuclear
cells. Then we analysed its effects on osteoblasts and osteoclasts.
Methods: CCL20 and CCR6 expression was evaluated in sub-
chondral bone tissue biopsies by immunohistochemical techniques
and the percentage of positive cells was manually counted. Func-
tional assays (cell proliferation, matrix proteins expression, apop-
totic markers, signalling factor and osteoclast differentiation) on
osteoblasts and osteoclasts were performed to assess the func-
tional role of CCL20.
Results: CCL20 was positive on osteoblasts (60%) and osteo-
cytes (20%) from RA patients, while it was expressed only in
OA osteoblasts located in area of new bone formation. Both in
OA and RA biopsies, osteoclasts were highly positive to CCL20
while mononuclear cells were 10% positive in OA and 60% in
RA. The percentage of osteoblasts positive to CCR6 was not
different in OA versus RA biopsies, while the percentage of os-
teocytes and mononuclear cells positive to CCR6 was signiﬁcantly
higher in RA compared to OA. CCL20 did not affected both
the expression of different matrix proteins (i.e. bone sialopro-
tein, collagen type I, osteopontin and osteocalcin) and apoptotic
markers (like caspases 3 and 8) in OA and RA osteoblasts.
CCL20-stimulated OA osteoblasts showed a signiﬁcant increase
in β-N-acetylhexosaminidase release compared to RA while os-
teoblasts proliferation was higher only in CCL20-stimulated RA
osteoblasts associated to Akt phosphorylation. IL1β and TNFα
differently modulated CCL20, RANKL/OPG expression in OA and
RA osteoblasts. Moreover, we found that CCL20 was an early
inducer (at day3) of cell fusion events, osteoclasts differentiation
and MMP-9 release.
Conclusions: This study demonstrates a different expression of
CCL20 positive osteoblasts in OA versus RA disease that seems
to be associated with the presence of inﬁltrating mononuclear
cells. Moreover, the contemporary action of CCL20 on osteoblasts
and osteoclasts that resulted in a greater proliferative response
in RA osteoblasts compared to OA and an increased enzymatic
activity in OA osteoblasts, clearly suggests a differential role of
this chemokine in OA and RA.
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Purpose: To elucidate the expression and function of nuclear
receptor retinoid-related orphan receptor alpha1 (RORalpha1) in
human MG-63 osteoblast-like cells.
